16 September 2020: Clinical Research
Short-Term Outcomes of Laparoscopic Duodenum-Preserving Total Pancreatic Head Resection Compared with Laparoscopic Pancreaticoduodenectomy for the Management of Pancreatic-Head Benign or Low-Grade Malignant Lesions
Xuemin Chen 1ADG* , Weibo Chen 1BEG* , Yue Zhang 1BC , Yong An 1B , Xiaoying Zhang 2ADF*DOI: 10.12659/MSM.927248
Med Sci Monit 2020; 26:e927248
Table 1 Demographics of the patients.
| Parameters | LDPPHRt (n=15) | LPD (n=39) | P value |
|---|---|---|---|
| Age (y) | 54.7±13.9 | 61.5±11.9 | 0.075 |
| Sex (n,%) | |||
| Male | 4 (26.7%) | 24 (61.5%) | |
| Female | 11 (73.3%) | 15 (38.5%) | |
| BMI (kg/m) | 22.8±2.3 | 23.4±2.4 | 0.409 |
| ASA (n, %) | 0.708 | ||
| II | 13 (86.7) | 31 (79.5%) | |
| III | 2 (13.3) | 8 (20.5%) | |
| Hemoglobin (g/L) | 135±10.8 | 138±13.3 | 0.44 |
| ALT (U/L) | 24 (13–34) | 23 (13–31) | 0.992 |
| AST (U/L) | 23 (20–32) | 20 (17–29) | 0.379 |
| Albumin (g/L) | 40.5±4.1 | 41.0±4.9 | 0.728 |
| Preoperative total bilirubin (mmol/L) | 10.3 (8.8–28.4) | 11.2 (8.5–16.0) | 0.565 |
| Preoperative direct bilirubin (mmol/L) | 6.6 (3.3–18.2) | 4.1 (3.2–5.8) | 0.338 |
| Preoperative CA19-9 (U/mL) | 11.1 (6.1–15.8) | 12.5 (6.85–25.4) | 0.428 |
| Preoperative CEA (ng/mL) | 2.4 (1.4–3.6) | 2.8 (1.7–3.9) | 0.308 |
| Preoperative CA125 (ng/mL) | 9.8 (7.0–11.5) | 12.5 (9.4–14.9) | 0.065 |
| Abdominal surgery history | 0 (0%) | 9 (20.1%) | |
| Preoperative initial symptoms (n,%) | 0.514 | ||
| Abdominal pain | 6 (40%) | 14 (25.6%) | |
| Jaundice | 2 (13.3%) | 5 (12.8%) | |
| Syncope | 1 (6.7%) | 0 (0%) | |
| Routine examination | 6 (40%) | 20 (51.3%) | |
| Hypertension (n, %) | 3 (20%) | 13 (33.3%) | 0.508 |
| Diabetes (n, %) | 2 (13.3%) | 4 (10.3) | 0.539 |
| BMI – body mass index; ALT – alanine aminotransferase; AST – aspartate aminotransferase; CA19-9 – carbohydrate antigen 19-9; CA125 – carbohydrate antigen 125. | |||